Page last updated: 2024-12-06

cocaethylene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

cocaethylene: RN given refers to (1R-(exo,exo))-isomer; cocaine metabolite produced in vivo when cocaine and ethanol are taken together; as potent as cocaine in blocking uptake of the neurotransmitter dopamine synapses [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID644006
CHEBI ID174315
SCHEMBL ID25282
MeSH IDM0182335

Synonyms (38)

Synonym
ethyl (1r,2r,3s,5s)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate
CHEBI:174315
cocaethylin
cocaethylene
ethylcocaine
homococaine
[1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid ethyl ester
cocaethyline
o-benzoyl-l-ecgonine ethyl ester
529-38-4
8-azabicyclo[3.2.1]octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, ethyl ester, (1r,2r,3s,5s)- (9ci)
benzoylethylecgonin
ethyl benzoylecgonine
ecgonine ethyl ester benzoate (ester)
cocethyline
brn 6117763
8-azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, ethyl ester, (1r-(exo,exo))-
0-22-00-00209 (beilstein handbook reference)
unii-fjo3071w5y
fjo3071w5y ,
ethyl cocaine
(1r,2r,3s,5s)-3-(benzoyloxy)-8-methyl-8-azabicyclo(3.2.1)octane-2-carboxylic acid ethyl ester
cocaethylene [mi]
SCHEMBL25282
cocaethylene, analytical standard
cocaine-m cocaethylene
cocaethylene (benzoylethylecgonine) 1.0 mg/ml in acetonitrile
cocaethylene; benzoylethylecgonine
cocaethylene (benzoylethylecgonine)
cocaethylene (benzoylethylecgonine) 0.1 mg/ml in acetonitrile
CS-7297
HY-U00306
(1r,2r,3s)-ethyl 3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate
DTXSID20873213
Q4586731
8-azabicyclo[3.2.1]octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, ethyl ester, (1r,2r,3s,5s)-
ethyl (1r,2r,3s,5s)-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate
cocaethylene, 1mg/ml in acetonitrile

Research Excerpts

Toxicity

Cocaine, norcocaine,. cocaethylene, benzoylecgonine, and ecgonine methyl ester were infused intravenously to produce sequential behavioral alterations and central nervous system and cardiovascular toxic effects. Ethanol might exacerbate cocaine hepatocyte toxicity by three different pathways.

ExcerptReferenceRelevance
"Although cocaine abuse has been a major drug problem in the United States for over 100 years, it has only been in the last decade that the adverse effects of cocaine on the cardiovascular system have become a serious health issue."( Cellular mechanisms of cocaine cardiotoxicity.
Grammas, P; Melchert, RB; Welder, AA, 1993
)
0.29
" Because cocaine and anabolic-androgenic steroids are used improperly, more focus needs to be paid to the toxic mechanisms of their adverse effects."( Cardiotoxic effects of cocaine and anabolic-androgenic steroids in the athlete.
Melchert, RB; Welder, AA, 1993
)
0.29
"Cocaine, norcocaine, cocaethylene, benzoylecgonine, and ecgonine methyl ester were infused intravenously to produce sequential behavioral alterations and central nervous system and cardiovascular toxic effects."( The comparative toxicity of cocaine and its metabolites in conscious rats.
Cooper, TB; Iso, A; Morishima, HO; Whittington, RA, 1999
)
0.3
"The dose of norcocaine necessary to produce toxic effects was smaller than that of cocaine and cocaethylene."( The comparative toxicity of cocaine and its metabolites in conscious rats.
Cooper, TB; Iso, A; Morishima, HO; Whittington, RA, 1999
)
0.3
"These results indicate that benzoylecgonine and ecgonine methyl ester are not as toxic as cocaine, norcocaine, or cocaethylene when administered intravenously to pharmacologically naive rats."( The comparative toxicity of cocaine and its metabolites in conscious rats.
Cooper, TB; Iso, A; Morishima, HO; Whittington, RA, 1999
)
0.3
" Ethanol might exacerbate cocaine hepatocyte toxicity by three different pathways: a) by increasing the oxidative metabolism of cocaine and hence the oxidative damage; b) by the formation of a more toxic metabolite, namely cocaethylene; or c) by decreasing the defence mechanisms of the cell (i."( Increased toxicity of cocaine on human hepatocytes induced by ethanol: role of GSH.
Bort, R; Castell, JV; Gómez-Lechón, MJ; Jover, R; Ponsoda, X, 1999
)
0.3

Pharmacokinetics

ExcerptReferenceRelevance
"67 l/h), had a longer elimination half-life (1."( Comparison in humans of the potency and pharmacokinetics of intravenously injected cocaethylene and cocaine.
Cook, CE; Jeffcoat, AR; Myers, M; Perez-Reyes, M; Sihler, K, 1994
)
0.29
"kg-1, is rapidly eliminated with a half-life of 29 min and a total body clearance of 77 ml."( In vivo pharmacokinetics and in vitro production of cocaethylene in pregnant guinea pigs.
Konkol, RJ; Kron, JE; Olsen, GD, 1996
)
0.29
" These data may be useful in investigating the pharmacokinetic profiles of COC and CE in humans and may also help to explain the longer plasma half-life of CE relative to that of COC."( Cocaine- and cocaethylene-creatinine clearance ratios in humans.
Bailey, DN; Bessler, JB; Sawrey, BA,
)
0.13
" This analytical method was designed for use in pharmacokinetic experiments studying the formation of cocaethylene following ethanol pretreatment in rats administered cocaine."( Quantitation of cocaine and cocaethylene in small volumes of rat whole blood using gas chromatography-mass spectrometry.
Boni, RL; Burdick, JD; Fochtman, FW, 1997
)
0.3
" Pharmacokinetic and pharmacodynamic parameters were compared between the two treatment phases by a paired t test."( Pharmacodynamic evaluation of the cardiovascular effects after the coadministration of cocaine and ethanol.
Laizure, SC; Parker, RB, 2009
)
0.35

Compound-Compound Interactions

ExcerptReferenceRelevance
" The effects of ethanol combined with cocaine on the exocrine pancreas are not known."( Ethanol combined with cocaine inhibits amylase release in guinea pig pancreatic lobules.
Antonilli, L; Linari, G; Nencini, P; Nucerito, V, 2001
)
0.31
" Indeed, there are numerous commonly prescribed drugs with significant carboxylesterase-mediated metabolism such as enalapril, lovastatin, irinotecan, clopidogrel, prasugrel, methylphenidate, meperidine, and oseltamivir that may interact with ethanol."( The effect of ethanol on oral cocaine pharmacokinetics reveals an unrecognized class of ethanol-mediated drug interactions.
Laizure, SC; Parker, RB, 2010
)
0.36

Bioavailability

Cocaethylene bioavailability is only 58% that of cocaine, according to the study.

ExcerptReferenceRelevance
" Comparison of dose corrected areas under the curve of the two routes of administration for each drug indicated that relative systemic bioavailability of cocaethylene following intraperitoneal administration is only 58% that of cocaine."( Differences in bioavailability between cocaine and cocaethylene and their implications for drug-reward studies.
Bradberry, CW; Jatlow, PI; Nobiletti, JB, 1994
)
0.29
" In addition, acute intraperitonecal administration at several doses (10, 15, or 25 mg/kg) confirmed previous reports of increased bioavailability of cocaine in brain and plasma relative to cocaethylene."( Sensitization to the locomotor activating effects of cocaine following cocaethylene-preexposure.
Elsworth, JD; Horger, BA; Jatlow, PI; Roth, RH; Taylor, JR, 1996
)
0.29
" Cocaine had poor systemic bioavailability with an area under the plasma concentration-time curve that was approximately 4-fold higher after intravenous than after oral administration."( The effect of ethanol on oral cocaine pharmacokinetics reveals an unrecognized class of ethanol-mediated drug interactions.
Laizure, SC; Parker, RB, 2010
)
0.36

Dosage Studied

Coca-ethanol trained animals were more sensitive to the lower doses of cocaine. Cocaine and alcohol shifted the dose-response function for cocaethylene to the left and down.

ExcerptRelevanceReference
" Further, cocaethylene shifted the dose-response functions for both cocaine and alcohol to the left and down, while cocaine and alcohol shifted the dose-response function for cocaethylene to the left and down."( The interaction of cocaethylene and cocaine and of cocaethylene and alcohol on schedule-controlled responding in rats.
Riley, AL; Sobel, BF, 1999
)
0.3
"1mg/kg/injection) dose-response curves were determined."( A comparison of the reinforcing strength of cocaethylene and cocaine in monkeys responding under progressive-ratio and concurrent choice schedules of reinforcement.
Allen, MI; Johnson, BN; Nader, MA, 2023
)
0.91
" The screening and the subsequent dosage revealed the following substances: cocaine (86 ng/mL), benzoylecgonine (383 ng/mL), cocaethylene (17 ng/mL), ecgonine methyl ester (130 ng/mL), caffeine, cuscohygrine, cinnamoylcocaine and synephrine."( Mariani wine: What's really in it? Analysis of the most popular tonic drink of the 19th century after 100 years of storage.
Arbouche, N; de Lestrange, A; Kintz, P; Raul, JS, 2024
)
1.44
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzoate esterEsters of benzoic acid or substituted benzoic acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (265)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's141 (53.21)18.2507
2000's60 (22.64)29.6817
2010's49 (18.49)24.3611
2020's15 (5.66)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials15 (4.95%)5.53%
Reviews11 (3.63%)6.00%
Case Studies8 (2.64%)4.05%
Observational0 (0.00%)0.25%
Other269 (88.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Cocaethylene Substitution Therapy and Tolerance Induction in Treating Cocaine Dependence [NCT00124696]Phase 18 participants Interventional2002-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]